FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2098210009> ?p ?o ?g. }

• W2098210009 endingPage "317" @default.
• W2098210009 startingPage "310" @default.
• W2098210009 abstract "The folate receptor (FR) is overexpressed on epithelial cancers (FR-α) and on activated, but not resting, macrophages (FR-β) involved in a variety of inflammatory and autoimmune diseases. Therefore, folate-based radiopharmaceuticals have the potential to be used as imaging agents of FR-positive tumor and inflammatory cells. In this study SPECT/CT of FR-positive malignant and normal tissues and organs in mice was performed using an improved organometallic ^99mTc-radiofolate. <b>Methods:</b> The ^99mTc radiolabeling of the histidine-folate was performed using the tricarbonyl technique described earlier for preparation of other organometallic radiofolates. Nude male mice with FR-positive KB tumor xenografts were used. Biodistribution studies were performed 1, 4, and 24 h after injection of the ^99mTc-His-folate (1.5 MBq/mouse). Images were acquired with a dedicated small-animal SPECT/CT camera 24 h after injection of the radiofolate (500 MBq/mouse). Ex vivo autoradiography was performed on tumors and FR-positive normal tissues. Adjacent sections were used for in vitro autoradiography of FRs after decay of the injected radioactivity. <b>Results:</b> The SPECT/CT studies revealed accumulation of the radiotracer in FR-positive KB tumor xenografts and kidneys as reported previously. At the same time, specific uptake of the radiofolate in normal tissues—that is, salivary glands and choroid plexus—could be visualized with SPECT. FR-specific accumulation in these tissues and organs was confirmed by coinjection of excess folic acid, which resulted in a complete blockade of radiofolate uptake. In addition, ex vivo and in vitro autoradiography of these organs and tissues confirmed FR expression and displayed radioactivity distribution patterns almost identical to those found on SPECT images. In biodistribution studies we found a high tumor uptake (4.29 ± 0.67 %ID/g [percentage of the injected dose per gram of tissue], 4 h after injection) that was almost completely retained over time (3.51 ± 0.37 %ID/g, 24 h after injection). <b>Conclusion:</b> The novel ^99mTc-histidine-folate showed improved in vivo characteristics compared with other organometallic radiofolates that allowed imaging of FR-positive malignant (KB tumor xenografts) and kidneys. For the first time, to our knowledge, specific tracer uptake in salivary glands and the choroid plexus could be visualized using a high-resolution animal SPECT/CT camera." @default.
• W2098210009 created "2016-06-24" @default.
• W2098210009 creator A5007991478 @default.
• W2098210009 creator A5040369608 @default.
• W2098210009 creator A5041743198 @default.
• W2098210009 creator A5056614563 @default.
• W2098210009 creator A5087322137 @default.
• W2098210009 date "2008-01-16" @default.
• W2098210009 modified "2023-09-27" @default.
• W2098210009 title "SPECT Study of Folate Receptor-Positive Malignant and Normal Tissues in Mice Using a Novel ^99mTc-Radiofolate" @default.
• W2098210009 cites W166788437 @default.
• W2098210009 cites W175680929 @default.
• W2098210009 cites W1916273603 @default.
• W2098210009 cites W1967738525 @default.
• W2098210009 cites W1983046149 @default.
• W2098210009 cites W1988368614 @default.
• W2098210009 cites W1989254456 @default.
• W2098210009 cites W1993019497 @default.
• W2098210009 cites W1995094885 @default.
• W2098210009 cites W2005564022 @default.
• W2098210009 cites W2013919931 @default.
• W2098210009 cites W2019343336 @default.
• W2098210009 cites W2020489397 @default.
• W2098210009 cites W2021346914 @default.
• W2098210009 cites W2042801728 @default.
• W2098210009 cites W2043708980 @default.
• W2098210009 cites W2046528901 @default.
• W2098210009 cites W2046667997 @default.
• W2098210009 cites W2054759893 @default.
• W2098210009 cites W2060459188 @default.
• W2098210009 cites W2064015384 @default.
• W2098210009 cites W2084540229 @default.
• W2098210009 cites W2089645494 @default.
• W2098210009 cites W2116725368 @default.
• W2098210009 cites W2150451572 @default.
• W2098210009 cites W2151167346 @default.
• W2098210009 cites W2410262644 @default.
• W2098210009 cites W4247050894 @default.
• W2098210009 doi "https://doi.org/10.2967/jnumed.107.045856" @default.
• W2098210009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18199624" @default.
• W2098210009 hasPublicationYear "2008" @default.
• W2098210009 type Work @default.
• W2098210009 sameAs 2098210009 @default.
• W2098210009 citedByCount "73" @default.
• W2098210009 countsByYear W20982100092012 @default.
• W2098210009 countsByYear W20982100092013 @default.
• W2098210009 countsByYear W20982100092014 @default.
• W2098210009 countsByYear W20982100092015 @default.
• W2098210009 countsByYear W20982100092016 @default.
• W2098210009 countsByYear W20982100092017 @default.
• W2098210009 countsByYear W20982100092018 @default.
• W2098210009 countsByYear W20982100092019 @default.
• W2098210009 countsByYear W20982100092020 @default.
• W2098210009 countsByYear W20982100092021 @default.
• W2098210009 countsByYear W20982100092022 @default.
• W2098210009 countsByYear W20982100092023 @default.
• W2098210009 crossrefType "journal-article" @default.
• W2098210009 hasAuthorship W2098210009A5007991478 @default.
• W2098210009 hasAuthorship W2098210009A5040369608 @default.
• W2098210009 hasAuthorship W2098210009A5041743198 @default.
• W2098210009 hasAuthorship W2098210009A5056614563 @default.
• W2098210009 hasAuthorship W2098210009A5087322137 @default.
• W2098210009 hasBestOaLocation W20982100091 @default.
• W2098210009 hasConcept C121608353 @default.
• W2098210009 hasConcept C126322002 @default.
• W2098210009 hasConcept C142724271 @default.
• W2098210009 hasConcept C150903083 @default.
• W2098210009 hasConcept C185592680 @default.
• W2098210009 hasConcept C202751555 @default.
• W2098210009 hasConcept C207001950 @default.
• W2098210009 hasConcept C2776538271 @default.
• W2098210009 hasConcept C2777807558 @default.
• W2098210009 hasConcept C2780306303 @default.
• W2098210009 hasConcept C2984398910 @default.
• W2098210009 hasConcept C2989005 @default.
• W2098210009 hasConcept C529278444 @default.
• W2098210009 hasConcept C55493867 @default.
• W2098210009 hasConcept C71924100 @default.
• W2098210009 hasConcept C86803240 @default.
• W2098210009 hasConcept C96232424 @default.
• W2098210009 hasConceptScore W2098210009C121608353 @default.
• W2098210009 hasConceptScore W2098210009C126322002 @default.
• W2098210009 hasConceptScore W2098210009C142724271 @default.
• W2098210009 hasConceptScore W2098210009C150903083 @default.
• W2098210009 hasConceptScore W2098210009C185592680 @default.
• W2098210009 hasConceptScore W2098210009C202751555 @default.
• W2098210009 hasConceptScore W2098210009C207001950 @default.
• W2098210009 hasConceptScore W2098210009C2776538271 @default.
• W2098210009 hasConceptScore W2098210009C2777807558 @default.
• W2098210009 hasConceptScore W2098210009C2780306303 @default.
• W2098210009 hasConceptScore W2098210009C2984398910 @default.
• W2098210009 hasConceptScore W2098210009C2989005 @default.
• W2098210009 hasConceptScore W2098210009C529278444 @default.
• W2098210009 hasConceptScore W2098210009C55493867 @default.
• W2098210009 hasConceptScore W2098210009C71924100 @default.
• W2098210009 hasConceptScore W2098210009C86803240 @default.
• W2098210009 hasConceptScore W2098210009C96232424 @default.
• W2098210009 hasIssue "2" @default.

• next